Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 3 | 2012 | 124 | 0.880 |
Why?
|
| Spinal Cord Injuries | 4 | 2014 | 39 | 0.760 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2012 | 182 | 0.640 |
Why?
|
| Cell Differentiation | 3 | 2012 | 469 | 0.630 |
Why?
|
| Stem Cells | 3 | 2012 | 313 | 0.610 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2012 | 72 | 0.500 |
Why?
|
| Hybridomas | 2 | 2008 | 4 | 0.450 |
Why?
|
| Cancer Vaccines | 2 | 2008 | 24 | 0.440 |
Why?
|
| Nerve Regeneration | 3 | 2018 | 48 | 0.410 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2012 | 12 | 0.400 |
Why?
|
| Retina | 1 | 2012 | 61 | 0.400 |
Why?
|
| Adipose Tissue | 1 | 2012 | 349 | 0.330 |
Why?
|
| B-Lymphocytes | 2 | 2008 | 74 | 0.330 |
Why?
|
| Recovery of Function | 2 | 2009 | 199 | 0.320 |
Why?
|
| Neoplastic Stem Cells | 1 | 2008 | 99 | 0.290 |
Why?
|
| Glioblastoma | 1 | 2008 | 156 | 0.270 |
Why?
|
| Autoimmunity | 1 | 2006 | 32 | 0.260 |
Why?
|
| Cell Transplantation | 1 | 2006 | 64 | 0.260 |
Why?
|
| Stem Cell Transplantation | 2 | 2014 | 209 | 0.260 |
Why?
|
| Neurons | 2 | 2006 | 410 | 0.250 |
Why?
|
| Coculture Techniques | 3 | 2012 | 81 | 0.230 |
Why?
|
| Cell Separation | 3 | 2012 | 92 | 0.230 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 638 | 0.200 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 16 | 0.140 |
Why?
|
| Adult | 4 | 2012 | 9381 | 0.140 |
Why?
|
| Humans | 9 | 2018 | 32115 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2006 | 103 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2006 | 120 | 0.120 |
Why?
|
| Consensus | 1 | 2014 | 85 | 0.120 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2012 | 12 | 0.110 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 16 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2012 | 25 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2012 | 71 | 0.100 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 80 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2014 | 406 | 0.100 |
Why?
|
| Regenerative Medicine | 1 | 2014 | 201 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 1328 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2012 | 198 | 0.090 |
Why?
|
| Female | 4 | 2012 | 20016 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 560 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2009 | 3306 | 0.080 |
Why?
|
| Neoplasms | 1 | 1996 | 728 | 0.080 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2008 | 4 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 56 | 0.070 |
Why?
|
| Male | 3 | 2012 | 19218 | 0.070 |
Why?
|
| Aged | 2 | 2012 | 10314 | 0.070 |
Why?
|
| Protein Hydrolysates | 1 | 2006 | 1 | 0.070 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2006 | 7 | 0.070 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2006 | 8 | 0.070 |
Why?
|
| Intermediate Filament Proteins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Tubulin | 1 | 2006 | 12 | 0.070 |
Why?
|
| Cell Shape | 1 | 2006 | 28 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2006 | 41 | 0.070 |
Why?
|
| Middle Aged | 2 | 2012 | 11839 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 88 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 123 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 367 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 173 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 3990 | 0.040 |
Why?
|
| Quality Control | 1 | 2018 | 44 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 1996 | 15 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 1996 | 45 | 0.030 |
Why?
|
| Vaccination | 1 | 1996 | 138 | 0.030 |
Why?
|